Recent advances in host-directed therapies for tuberculosis and malaria (2022)
Source: Frontiers in Cellular and Infection Microbiology. Unidade: FMRP
Subjects: TUBERCULOSE, MALÁRIA, FARMACOTERAPIA, MYCOBACTERIUM TUBERCULOSIS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTEUCCI, Kely Catarine e CORREA, André Aparecido dos Santos e COSTA, Diego Luís. Recent advances in host-directed therapies for tuberculosis and malaria. Frontiers in Cellular and Infection Microbiology, v. 12, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.905278. Acesso em: 20 jan. 2026.APA
Matteucci, K. C., Correa, A. A. dos S., & Costa, D. L. (2022). Recent advances in host-directed therapies for tuberculosis and malaria. Frontiers in Cellular and Infection Microbiology, 12. doi:10.3389/fcimb.2022.905278NLM
Matteucci KC, Correa AA dos S, Costa DL. Recent advances in host-directed therapies for tuberculosis and malaria [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2026 jan. 20 ] Available from: https://doi.org/10.3389/fcimb.2022.905278Vancouver
Matteucci KC, Correa AA dos S, Costa DL. Recent advances in host-directed therapies for tuberculosis and malaria [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12[citado 2026 jan. 20 ] Available from: https://doi.org/10.3389/fcimb.2022.905278
